---
title: "Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286160504.md"
description: "Inovio Pharmaceuticals Inc. (INO) shares fell 1.40% to $1.41 on Tuesday, marking the second consecutive day of losses. The stock is currently 52.67% below its 52-week high of $2.98. In comparison, Johnson & Johnson (JNJ) rose 1.28%, while Pfizer Inc. (PFE) increased by 0.23%. The overall market showed mixed results, with the Dow Jones up 0.11% and NASDAQ down 0.71%. Trading volume for Inovio was 3.0 million, surpassing its 50-day average of 2.5 million."
datetime: "2026-05-12T21:25:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286160504.md)
  - [en](https://longbridge.com/en/news/286160504.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286160504.md)
---

# Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. (INO) shed 1.40% to $1.41 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.11% to 49,760.56 and the NASDAQ Composite Index falling 0.71% to 26,088.20.

This was the stock's second consecutive day of losses.

Inovio Pharmaceuticals Inc. closed 52.67% below its 52-week high of $2.98, which the company achieved on September 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 1.28% to $224.26, Statera Biopharma Inc. (STAB) fell 50.00% to $0.00, and Pfizer Inc. (PFE) rose 0.23% to $25.87.

Trading volume (3.0 M) eclipsed its 50-day average volume of 2.5 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 12, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

05-12-26 1725ET

### Related Stocks

- [INO.US](https://longbridge.com/en/quote/INO.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Inovio Pharmaceuticals held annual shareholder meeting, investors elected eight directors](https://longbridge.com/en/news/287111362.md)
- [Corvus Pharmaceuticals presents Phase 1 soquelitinib data showing durable remissions, favorable safety](https://longbridge.com/en/news/286404245.md)
- [INOVIO to Participate in Upcoming Scientific Conferences | INO Stock News](https://longbridge.com/en/news/285721077.md)
- [Eton Pharmaceuticals Q1 product sales rise driven by portfolio expansion](https://longbridge.com/en/news/286461579.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)